Market News & Trends
Verseon Reports First Dosing in Phase 1 Trial on New Precision Oral Drug
Verseon’s Phase 1 trial in healthy volunteers, which recently started dosing, could lead to a new treatment standard for millions of cardiac patients who would…
ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly
ProteoNic Biotechnology BV recently announced that it licensed its 2G UNic technology for boosting recombinant protein production to Eli Lilly and Company. Under the agreement,…
HiberCell Launches to Prevent Cancer Relapse & Metastasis With Novel Therapeutics
HiberCell recently launched with $60.75 million in Series A funding led by ARCH Venture Partners. HiberCell is the first company exclusively focused on tumor dormancy…
Evotec & Galapagos Enter Global Collaboration
Evotec AG and Galapagos NV recently announced a global collaboration focused on a novel target for fibrosis and other indications. The collaboration concerns a small…
argenx & Halozyme Enter Global Collaboration & License Agreement
argenx and Halozyme Therapeutics, Inc. recently announced a global collaboration and license agreement that enables use by argenx of Halozyme’s ENHANZE drug delivery technology to…
AIT Receives Milestone Payment From Commercialization Partner
AIT Therapeutics, Inc. recently announced it has received a milestone payment of $3.15 million from its commercialization partner Circassia Pharmaceuticals for the successful completion of…
Spero Therapeutics Announces Initiation of Clinical Trial
Spero Therapeutics, Inc recently announced it has initiated a Phase 1 clinical trial of SPR720, an orally administered antimicrobial agent being developed for the treatment…
MeiraGTx Enters Strategic Collaboration With Janssen
MeiraGTx Holdings plc recently announced it has entered into a broad strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson…
Hitachi Chemical to Acquire apceth Biopharma
Hitachi Chemical Advanced Therapeutics Solutions, LLC recently announced an agreement by which apceth Biopharma GmbH will join Hitachi Chemical’s PCT global services platform. apceth Biopharma…
Fortress Biotech Announces Strategic Partnership With Alexion
Fortress Biotech, Inc. recently announced that Caelum Biosciences, Inc. has signed a strategic agreement with Alexion Pharmaceuticals, Inc. to advance the development of CAEL-101 for…
EXCLUSIVE ONLINE CONTENT
Molex Expands European Manufacturing Footprint & Capabilities With State-of-the-Art Campus in Poland
Molex recently announced a major expansion of its global manufacturing footprint with the opening of a new campus in Katowice, Poland. The facility’s initial 23,000-square-meter manufacturing space will….
Kala Pharmaceuticals Completes Sale of EYSUVIS & INVELTYS to Alcon Inc
Kala Pharmaceuticals, Inc. recently announced it has completed the sale of its commercial portfolio and related intellectual property assets to Alcon Inc., a transaction that was….
Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics
Insightful Science recently announced it has completed the transaction to acquire Protein Metrics, Inc. to expand the company’s R&D value chain to widen the biopharmaceutical protein analysis arena….
Acer Therapeutics & Relief Therapeutics Announce NDA Submission for ACER-001 for Treatment of Urea Cycle Disorders
Acer Therapeutics Inc. Relief Therapeutics recently announced the submission of a New Drug Application (NDA) to the US FDA for ACER-001 (sodium phenylbutyrate) for the treatment of Urea Cycle Disorders (UCDs)….